Sermorelin

Sermorelin is a synthetic version of the first 29 amino acids of growth-hormone-releasing hormone, the portion responsible for stimulating the pituitary to release growth hormone. Unlike taking growth hormone directly, Sermorelin relies on the patient’s own pituitary response and preserves the body’s endogenous signaling pathway. Human research has shown that GHRH(1-29)—Sermorelin—can produce a clear growth-hormone response in normal men human study and has been studied pharmacokinetically in healthy adults research. Sermorelin is generally positioned around sleep-quality support, recovery, body composition, and healthy-aging goals, with the understanding that those wellness outcomes are less directly studied than the underlying GH-release mechanism.

Sermorelin works by signaling the pituitary gland to release more of the body’s own growth hormone. That growth-hormone pulse can raise downstream IGF-1 and may influence recovery, sleep architecture, protein turnover, and body-composition pathways. Human studies of GHRH(1-29) demonstrate that the peptide can stimulate GH release without directly supplying exogenous growth hormone study. For Bowery Clinic patients, the goal is typically to support physiologic GH signaling rather than to create a rapid stimulant or weight-loss effect. Results depend heavily on age, baseline GH reserve, sleep, nutrition, exercise, and overall endocrine health.

Sermorelin can be well tolerated in selected patients, but it still changes endocrine signaling and should be clinician-directed. Your clinician will review glucose metabolism, pituitary history, active cancer concerns, pregnancy status, other hormone therapies, and concurrent growth-hormone-axis peptides before starting treatment. Possible side effects can include injection-site reactions, flushing, headache, dizziness, tingling, or symptoms related to increased growth-hormone activity. Human studies of GHRH(1-29) reported a GH response with relatively limited acute side effects at studied doses, including transient flushing at higher doses.

Sermorelin increases growth-hormone release shortly after dosing, but wellness results develop more gradually. Sleep or recovery changes may be noticed within about 2–4 weeks, while body-composition goals are better evaluated after 8–12 weeks. Fuller changes may require several months of consistent treatment, nutrition, and resistance training.

Bowery Clinic peptides are higher-strength and clinically dosed compared to most research facilities that use much lower concentrations. They are compounded by licensed 503A pharmacies with physician oversight and sterile quality standards, prioritizing real therapeutic outcomes over cheaper, unregulated research-grade products.

Yes. All pharmacies in our network are fully licensed in the states where they operate and comply with all state board of pharmacy regulations. Unlike many peptide clinics, we partner exclusively with FDA-registered U.S. pharmacies that undergo rigorous evaluation and compliance checks.

Every patient receives treatment plans developed and monitored by licensed providers. This includes safe titration of dosages and ongoing medical oversight tailored to individual needs.

Injections deliver the medication directly into your system. This makes the absorption more consistent and effective. Troches are small dissolvable lozenges that sit in your mouth until they melt, slowly releasing medication through the lining of your cheek or under your tongue.